We are live on ! Find out more
EAM

EULAV Asset Management Portfolio holdings

AUM $3.13B
1-Year Est. Return 23.04%
This Fund
S&P 500
This Quarter Est. Return
+2.34%
1 Year Est. Return
+23.04%
3 Year Est. Return
+90.7%
5 Year Est. Return
+115.08%
10 Year Est. Return
+583.23%
AUM
$3.79B
AUM Growth
+$6.57M
Cap. Flow
-$29.8M
Cap. Flow %
-0.79%
Top 10 Hldgs %
19.67%
Holding
225
New
3
Increased
32
Reduced
59
Closed
3

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$12.9M
2
EXAS
Exact Sciences
EXAS
+$12.7M
3
DAL icon
Delta Air Lines
DAL
+$6.94M
4
ATVI
Activision Blizzard
ATVI
+$6.27M
5
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$5.2M

Top Sells

Rank Stock Value
1
ZEN
ZENDESK INC
ZEN
+$12.4M
2
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$9.74M
3
ANSS
Ansys
ANSS
+$8.61M
4
TDY icon
Teledyne Technologies
TDY
+$7.42M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.64M

Sector Composition

Rank Sector Weight
1 Technology 34%
2 Healthcare 17.11%
3 Industrials 15.63%
4 Financials 11.96%
5 Consumer Discretionary 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRI icon
176
Primerica
PRI
$9.98B
$2.8M 0.07%
18,200
– –
LPSN icon
177
LivePerson
LPSN
$21.8M
$2.78M 0.07%
3,140
– –
KAI icon
178
Kadant
KAI
$3.63B
$2.75M 0.07%
13,500
– –
MEDP icon
179
Medpace
MEDP
$16.1B
$2.73M 0.07%
14,400
+500
+4% +$91.2K
TREE icon
180
LendingTree
TREE
$447M
$2.71M 0.07%
19,400
– –
ZWS icon
181
Zurn Elkay Water Solutions
ZWS
$8.38B
$2.64M 0.07%
85,116
– –
RUSHA icon
182
Rush Enterprises Class A
RUSHA
$6.2B
$2.62M 0.07%
86,850
– –
LFUS icon
183
Littelfuse
LFUS
$11.2B
$2.51M 0.07%
9,200
– –
ACIW icon
184
ACI Worldwide
ACIW
$5.83B
$2.44M 0.06%
79,300
– –
MRCY icon
185
Mercury Systems
MRCY
$5.83B
$2.38M 0.06%
50,300
– –
FN icon
186
Fabrinet
FN
$15.6B
$2.36M 0.06%
23,000
– –
NSP icon
187
Insperity
NSP
$1.93B
$2.35M 0.06%
21,200
– –
ORLY icon
188
O'Reilly Automotive
ORLY
$72.9B
$2.32M 0.06%
57,000
– –
NPO icon
189
Enpro
NPO
$6.63B
$2.3M 0.06%
26,400
– –
CVGW
190
DELISTED
Calavo Growers
CVGW
$2.26M 0.06%
59,200
– –
SFIX
191
Stitch Fix
SFIX
$536M
$2.22M 0.06%
55,546
– –
NOC icon
192
Northrop Grumman
NOC
$77.1B
$2.16M 0.06%
6,000
– –
AIT icon
193
Applied Industrial Technologies
AIT
$12.8B
$2.1M 0.06%
23,300
– –
PLNT icon
194
Planet Fitness
PLNT
$4.42B
$2.1M 0.06%
26,700
– –
PENN icon
195
PENN Entertainment
PENN
$2.75B
$1.95M 0.05%
26,900
-1
-0% -$74
RNR icon
196
RenaissanceRe
RNR
$13.3B
$1.88M 0.05%
13,500
– –
TXRH icon
197
Texas Roadhouse
TXRH
$13.5B
$1.81M 0.05%
19,800
– –
DY icon
198
Dycom Industries
DY
$12B
$1.78M 0.05%
24,939
-2
-0% -$141
ROG icon
199
Rogers Corp
ROG
$2.21B
$1.73M 0.05%
9,300
– –
OTEX icon
200
Open Text
OTEX
$6.15B
$1.71M 0.05%
35,024
– –
5 6 7
8
9

Similar funds

LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.12B AUM 12.93% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.12B AUM 25.62% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return

EULAV Asset Management's Q3 2021 Portfolio in Review

As of Q3 2021, EULAV Asset Management held 225 positions worth $3.79B, up 0.17% from $3.78B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 2.7%. EULAV Asset Management opened 3 new positions and exited 3, leaving the 225-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 34% a quarter earlier, followed by Healthcare and Industrials.

  • EULAV Asset Management's largest Q3 2021 buy was Edwards Lifesciences: 113,010 shares worth $12.8M.
  • EULAV Asset Management added most to Exact Sciences in Q3 2021, an estimated $12.7M increase.
  • EULAV Asset Management's biggest Q3 2021 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $9.74M.
  • EULAV Asset Management fully exited ZENDESK INC in Q3 2021, selling an estimated $12.4M.
  • EULAV Asset Management's ten largest holdings make up 20% of its $3.79B portfolio in Q3 2021.
  • EULAV Asset Management opened 3 new positions and closed 3 in Q3 2021.
  • EULAV Asset Management's portfolio value rose 0.17% quarter-over-quarter to $3.79B.

Based on EULAV Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.